Experts Urge Global Moratorium on mRNA Vaccines Amid Safety Concerns

Experts Urge Global Moratorium on mRNA Vaccines Amid Safety Concerns

In a groundbreaking peer-reviewed article published in Cureus, Journal of Medical Science, experts are calling for a global moratorium on mRNA vaccines until critical safety questions are thoroughly investigated. Cureus, known for its pre-publication peer review process, hosted this important research, shedding light on concerning aspects of COVID-19 vaccine trials and the global vaccination campaign.

The authors meticulously surveyed published research on vaccine trials conducted by pharmaceutical companies, examining related adverse events. Their findings have led them to advocate for the immediate removal of COVID-19 vaccines from childhood immunization schedules worldwide.

Initially hailed for their reported 95% effectiveness in preventing COVID-19, vaccine trials soon came under scrutiny for methodological flaws in execution and reporting. The authors delved into these issues, revealing significant concerns about safety and efficacy.

Alarmingly, the vaccines lacked adequate safety and toxicological testing before their rollout, leading to the identification of numerous adverse events and serious adverse events post-vaccination. Authors including M. Nathaniel Mead, Stephanie Seneff, Ph.D., Russ Wolfinger, Ph.D., Jessica Rose, Ph.D., Kris Denhaerynck, Ph.D., Steve Kirsch, and Dr. Peter McCullough detailed potential serious harms, vaccine control issues, and processing concerns.

Their analysis highlighted the need for a more transparent assessment of all relevant data before federal agencies grant blanket-coverage population-wide approvals. They called for immediate removal of vaccines from childhood immunization schedules and suspension of booster shots, citing ethical concerns over administering experimental vaccines to low-risk groups like children.

Moreover, the authors emphasized the necessity of a comprehensive investigation into potential misconduct by pharmaceutical companies and regulatory agencies. This study marks the first peer-reviewed call for a moratorium on mRNA COVID-19 products, representing a critical step towards ensuring public safety.

Lead author Mead stressed the importance of a thorough risk-benefit analysis, particularly regarding vaccine-induced mortality. The study outlined six key takeaways, including revelations about the reclassification of mRNA vaccines as gene therapies, overestimations of vaccine efficacy, underreporting of adverse events, and failure to adequately test for safety and toxicity.

The authors highlighted concerning discrepancies between trial data and real-world outcomes, raising questions about the vaccines’ true efficacy and safety profiles. They underscored the need for caution in evaluating vaccine benefits against potential risks, especially in light of mounting evidence suggesting adverse effects.

In conclusion, this groundbreaking study calls for urgent action to address safety concerns surrounding mRNA vaccines. The findings underscore the need for transparency, accountability, and thorough investigation in vaccine development and regulatory processes. Only through a rigorous and unbiased evaluation of available data can we ensure the safety and well-being of global populations amidst the ongoing COVID-19 pandemic.

Full article is here.

Share this post